Introduction
============

Upper oesophageal malignancies (proximal to gastro-oesophageal junction) are usually of the squamous cell type. Although glandular heterotropia of the upper digestive tract is frequently observed during upper gastrointestinal endoscopy (in 0.26%--4.9% of cases), it has rare malignant potential. Adenocarcinoma of the upper oesophagus is not commonly observed and only 29 cases have been reported so far \[[@ref1]--[@ref8]\]. We are reporting on the 30th case of adenocarcinoma of the upper oesophagus in an Asian female.

Case report
===========

The 50-year-old patient, complained of progressive difficulty in swallowing for four months, having had only liquid intake at the time of our workup. There was no history of tuberculosis, hypertension, chronic obstructive pulmonary disease, diabetes, any other chronic ailment, or significant family history. Blood biochemistry, including liver and kidney functions, was within normal limits. Ultrasound of the patient's abdomen was normal. A barium swallow ([Figure 1](#figure1){ref-type="fig"}) revealed a filling defect in the mid-thoracic oesophagus with shouldering effect and a hold-up of barium proximal to it. The CECT of the thorax ([Figure 2](#figure2){ref-type="fig"}) showed circumferential thickening of the oesophagus from carina to a distance of 4.5-cm. Fat plane with trachea and aorta was maintained. The gastro-oesophageal junction was not involved. The CECT of the abdomen showed normal liver, spleen, pancreas, and kidneys. No free fluid or lymphadenopathy was seen. Upper gastrointestinal endoscopy detected an ulcero-nodular, friable, obstructive growth at 22-cm from the incisor teeth; a scope negotiation below it was not possible. A biopsy ([Figure 3](#figure3){ref-type="fig"}) of growth revealed poorly differentiated adenocarcinomas. Alpha fetoprotein and serum transferrin were also within normal limits (3.1 ng/ml and 322 mg/dl). The option of surgery was given, but the patient was not willing to have any surgical intervention. In view of the moderate nutritional status and a poor oral intake, a palliative external beam radiotherapy (EBRT) was given; as 20-Gy in five fractions over five days by AP/PA fields, using telecobalt, along with supportive treatment. Oral intake and general condition improved in the following four weeks and supplementary EBRT as 12-Gy in six fractions over one week was given. Supplementary intraluminal brachytherapy was offered in view of the good response to radiotherapy, but the patient refused. At third monthly follow-up, the patient was having an adequate semisolid and occasionally solid diet. Her general condition also improved, with no additional complaints.

Discussion
==========

Occurrence of adenocarcinoma is rare and has been explained in the literature on the basis of ectopic gastric type mucosa in the upper part of the oesophagus. The incidence of ectopic gastric mucosa is 4.0% in males and 2.9% in females \[[@ref9]\]. [Table 1](#table1){ref-type="table"} summarizes all these cases including this case report.

The age at presentation varies from 37 to 90 years with a mean age of 63 years. Out of 30 cases, only three are female with a male to female ratio of 9:1, which is a little higher than the ratio for overall oesophageal malignancies (3.5:1) \[[@ref10]\]. In general, radical surgery is the mainstay of treatment. Radiotherapy is a good alternative, especially when surgery is refused or not feasible. Beyond doubt, treatment modality needs to be individualized based on disease, the patient's condition, and other parameters. The gradual increase in the number of cases of upper oesophageal adenocarcinoma warrants the standardization of treatment protocol.
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###### Summary of cases reported to date.

  Sr. no.   Year   First author       Histological type          Age (years)   Gender
  --------- ------ ------------------ -------------------------- ------------- --------
  1         1950   Carrie A           Adenocarcinoma             64            M
  2         1969   Davis WM           Mucinous Adenocarcinoma    68            M
  3         1970   Sakamoto G         Papillary adenocarcinoma   64            M
  4         1974   Clemente C         Int. type adenocarcinoma   53            M
  5         1985   Schmidt H          Adenocarcinoma             37            M
  6         1985   Schmidt H          Adenocarcinoma             54            M
  7         1986   Endo T             Adenosquamous carcinoma    73            M
  8         1987   Christensen WN     PD adenocarcinoma          52            M
  9         1987   Christensen WN     MD adenocarcinoma          50            M
  10        1987   Danoff B           PD adenocarcinoma          43            M
  11        1989   Kamiya J           MD adenocarcinoma          58            M
  12        1991   Ishii K            WD adenocarcinoma          66            M
  13        1993   Kubota S           Papillary adenocarcinoma   58            M
  14        1994   Takagi Y           MD adenocarcinoma          85            M
  15        1995   Takagi A           WD adenocarcinoma          70            M
  16        1995   Sperling RM        PD adenocarcinoma          79            M
  17        1996   Kammori M          WD adenocarcinoma          74            F
  18        1997   Pai S              MD adenocarcinoma          60            M
  19        1997   Berkelhammer C     MD adenocarcinoma          71            M
  20        1997   Yamamoto S         Adenocarcinoma             90            F
  21        1998   Lauwers GY         MD adenocarcinoma          57            M
  22        2001   Noguchi T          WD adenocarcinoma          73            M
  23        2002   Chatelaine D       PD adenocarcinoma          61            M
  24        2004   Kagawa N           MD adenocarcinoma          51            M
  25        2004   Abe T              WD adenocarcinoma          50            M
  26        2005   Alrawi SJ          MD adenocarcinoma          60            M
  27        2006   Masashi T          Adenocarcinoma             53            M
  28        2010   Komori S           Adenocarcinoma             75            M
  29        2011   Bard A             Adenocarcinoma             87            M
  30        2012   **PRESENT CASE**   PD adenocarcinoma          50            F
